U.S. markets closed

Synthetic Biologics, Inc. (SYN)

NYSE American - NYSE American Delayed Price. Currency in USD
Add to watchlist
0.5020+0.0414 (+8.99%)
At close: 4:00PM EDT
Full screen
Loading interactive chart...
  • Synthetic Biologics Reports 2021 First Quarter Operational Highlights and Financial Results
    PR Newswire

    Synthetic Biologics Reports 2021 First Quarter Operational Highlights and Financial Results

    Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, today provided a clinical programs update and reported financial results for the quarter ended March 31, 2021.

  • ACCESSWIRE

    Synthetic Biologics, Inc. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Synthetic Biologics, Inc. (AMEX:SYN) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.

  • Synthetic Biologics to Report 2021 First Quarter Operational Highlights and Financial Results on May 5, 2021
    PR Newswire

    Synthetic Biologics to Report 2021 First Quarter Operational Highlights and Financial Results on May 5, 2021

    Synthetic Biologics, Inc. (NYSE American: SYN), a diversified clinical-stage company leveraging the microbiome to develop therapeutics designed to prevent and treat gastrointestinal (GI) diseases in areas of high unmet need, announced today that the Company intends to release its operational highlights and financial results for the quarter ended March 31, 2021 on Wednesday, May 5, 2021, and to host a conference call the same day at 4:30 p.m. ET. The dial-in information for the call is as follows: